Clinical Trial Update: IMG-7289 in Patients With Essential Thrombocythemia (ET) or Polycythemia Vera (PV) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for IMG-7289 in essential thrombocythemia and polycythemia vera; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Thrombocythemia
• Polycythemia Vera

Drugs mentioned

• IMG-7289 (LSD1 inhibitor)

Snippet

Sponsor: Terrence J Bradley, MD | Conditions: Essential Thrombocythemia, Polycythemia Vera | Phase 2 | Status: ACTIVE_NOT_RECRUITING